1.Nast A, Rosumeck S, Erdmann R, Alsharif U, Werner RN. Methods report on the development of the European evidence-based (S3) guideline for the treatment of acne - update 2016. Journal of the European Academy of Dermatology & Venereology. 2016;30:e1–1e28.
2.Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol.:S0190962215026146.
3.Harper JC. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol. 2004. 51(1): 36–38.
4.Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brandmiller J. Acne Vulgaris: A Disease of Western Civilization. Arch Dermatol. 2002;138:1584–90.
5.Vilar GN, Santos LA, Sobral Filho JF. Quality of life, self-esteem and psychosocial factors in adolescents with acne vulgaris. An Bras Dermatol. 2015. 90(5): 622–629.
6.Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2015. 145(2): 274–279.
[7 Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 2015;140:672–676.
8.Bez Y, Yesilova Y, Kaya MC, Sir A. High social phobia frequency and related disability in patients with acne vulgaris. European Journal of Dermatology Ejd. 2011. 21(5): 756.
9.Fox L, Csongradi C, Aucamp M, Du PJ, Gerber M. Treatment Modalities for Acne. Molecules. 2016. 21(8): 1063.
10.Cao HJ, Yang GY, Wang YY, Liu JP. Acupoint Stimulation for Acne: A Systematic Review of Randomized Controlled Trials. Med Acupunct. 2013. 25(3): 173–194.
11.Son BK, Yun Y, Choi IH. Efficacy of point acupuncture on acne vulgaris. Acupunct Med. 2010. 28(3): 126–129.
12.Tan EK, Millington GW, Levell NJ. Acupuncture in dermatology: an historical perspective. Int J Dermatol. 2010. 48(6): 648–652.
13.Dong BQ, Li LZ, Zhang SJ. Acupuncture at back-shu points with long-round needle for 194 cases of acne. Zhongguo Zhen Jiu 2011;31:850.
14.Wang Q, Wang G. Therapeutic effect observation on treatment of acne with acupuncture plus moving cupping and blood-letting. Journal of Acupuncture and Tuina Science. 2008. 6(4): 212–214.
15.Chelsea M, Sivamani RK, Pfab F. Acupuncture as a treatment modality in dermatology: a systematic review. Deutsche Zeitschrift Für Akupunktur. 2016. 59(1): 31–31.
16.Cyrulnik AA, Viola KV, Gewirtzman AJ, Cohen SR. High‐dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life. Int J Dermatol. 2012;51.
17.Hayashi N, Makoto K. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: A multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. J Dermatol. 38:111–9.18.]Moher D, Chan A. SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials). 2014.
19.Macpherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. STandards for Reporting Interventions in Controlled Trails of Acupuncture. Clinical Acupuncture & Oriental Medicine. 2002. 3(1): 6–9.
20.Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–73.e33.
21.Descamps V. Clinical Guidelines for Management of Acne Vulgaris. JAMA. 2017. 317(2): 213.
22.Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 2010. 36(6): 416–418.
23.Huang LX, Zhao JS, Wu ZC, Wu XD, Tan YS. [Editorial explanation on the state standard The Name and Location of Acupoints (2006, edition)]. Zhongguo Zhen Jiu. 2009. 29(11): 924–926.
24Leihong Xiang. Guideline for diagnosis and treatment of acne (the 2014 revised editon).J Clin Dermatol. 2015;(1): 52–57.
25.Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996. 107(5): 707–713.
26.Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of skindex–16: A brief quality-of-life measure for patients with skin diseases. Journal of Cutaneous Medicine & Surgery. 2001. 5(2): 105–110.
27.Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clinical & Experimental. Dermatology. 2010. 19(3): 210–216.
28.Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data. Dermatology. 2015. 230(1): 27–33.
29.Palli MB, Reyeshabito CM, Lima XT, Kimball AB. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris. Journal of Drugs in Dermatology Jdd. 2013. 12(6): 633–7.
30.Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92:497.
31.Ramli R, Malik AS, Hani AFM, Jamil A. Acne analysis, grading and computational assessment methods: an overview. Skin Research & Technology. 18:1–14.
32. Kim K, Kim KI, Lee J. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesions and facial heat in patients with acne vulgaris: A randomized controlled trial protocol. Bmc Complementary & Alternative Medicine. 2015. 16(1): 21.
33.Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: A retrospective examination. J Cosmet Dermatol. 2010;9:59–63.
34.Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2012;168:474–85.
35.Gupta M. The development of an acne quality of life scale: Reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol. 1998;78:451.
36.Perneger TV, Leplège A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF–36) in young healthy adults. J Clin Epidemiol. 1995;48:1051–60.
37.Meriggi F, Rizzi A, Andreis F, Rota L, Mazzocchi M, Di Biasi B, et al. Skindex–29 (SD–29) for health-related quality of life (HRQoL) assessment during antiEGFr therapies for colorectal cancer (CRC). 2008;26:20721.38.Vickers AJ. Placebo controls in randomized trials of acupuncture. Eval Health Prof. 2002. 25(4): 421–435.
39.Liu B, Xu H, Ma R, Mo Q, Yan S, Liu Z. Effect of blinding with a new pragmatic placebo needle: a randomized controlled crossover study. Medicine (Abingdon). 2014. 93(27): e200.